Vitro Diagnostics Inc (fka VODG)

[TomFromYahoo]

They filed another 8-K today with the SEC, to document what appears to be the remaining $1,000,000 of the $3,000,000 they authorized last fall. Again, my assumption is this funding is in lieu of the failed IPO to (a) pay the bills for a year or two, and, presumably (b) to start one of the clinical trials. If all of that is true, I would expect them to announce the initiation of one of the trials with some public fanfare in Q1, while simultaneously trying to enter the NASDAQ through the back door, as previously discussed. I assume the theory is that the juice of initiating a clinical trial will provide the momentum to price the shares adequately. But who really knows. Until the apparently deaf and mute CEO addresses the shareholders, it is all conjecture.